EMPLICITI vs MOZOBIL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. EMPLICITI and MOZOBIL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EMPLICITI	MOZOBIL
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ELOTUZUMAB	PLERIXAFOR
Manufacturer	Bristol Myers Squibb	Genzyme
Dosage forms	Injectable	Injectable
Drug class	—	Hematopoietic Stem Cell Mobilizer
Boxed warning	None	None
Treats	Multiple Myeloma	Non-Hodgkin Lymphoma, Multiple Myeloma

empliciti mozobil

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

ELOTUZUMAB

PLERIXAFOR

Manufacturer

Bristol Myers Squibb

Genzyme

Dosage forms

Injectable

Drug class

—

Hematopoietic Stem Cell Mobilizer

Boxed warning

None

Treats

Multiple Myeloma

Non-Hodgkin Lymphoma, Multiple Myeloma

Frequently asked questions

Which is better-rated, Empliciti or Mozobil?

Empliciti and Mozobil are tied at 3.6 out of 5 by our independent rating.

What is the difference between Empliciti and Mozobil?

Empliciti contains Elotuzumab, while Mozobil contains Plerixafor — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.